Changes in Integrity of Normal-Appearing White Matter in Patients with Moyamoya Disease: A Diffusion Tensor Imaging Study

References

1. 1.↵
   1. Suzuki J,
   2. Takaku A

   . Cerebrovascular “Moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288–99

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Yamada I,
   2. Himeno Y,
   3. Nagaoka T,
   4. et al

   . Moyamoya disease: evaluation with diffusion-weighted and perfusion echo-planar MR imaging. Radiology 1999;212:340–47

   PubMed
3. 3.↵
   1. Calamante F,
   2. Ganesan V,
   3. Kirkham FJ,
   4. et al

   . MR perfusion imaging in Moyamoya syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke 2001;32:2810–16

   Abstract/FREE Full Text
4. 4.↵
   1. Le Bihan D

   . Diffusion, perfusion and functional magnetic resonance imaging. J Mal Vasc 1995;20:203–14

   PubMed
5. 5.↵
   1. Le Bihan D,
   2. Breton E,
   3. Lallemand D,
   4. et al

   . MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401–07

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Chenevert TL,
   2. Brunberg JA,
   3. Pipe JG

   . Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology 1990;177:401–05

   PubMedWeb of Science
7. 7.↵
   1. Basser PJ,
   2. Pierpaoli C

   . Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996;111:209–19

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Buchsbaum MS,
   2. Tang CY,
   3. Peled S,
   4. et al

   . MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 1998;9:425–30

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Werring DJ,
   2. Clark CA,
   3. Barker GJ,
   4. et al

   . Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999;52:1626–32

   Abstract/FREE Full Text
10. 10.↵
    1. Chabriat H,
    2. Pappata S,
    3. Poupon C,
    4. et al

    . Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke 1999;30:2637–43

    Abstract/FREE Full Text
11. 11.↵
    1. O'Sullivan M,
    2. Summers PE,
    3. Jones DK,
    4. et al

    . Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 2001;57:2307–10

    Abstract/FREE Full Text
12. 12.↵
    1. Shiraishi A,
    2. Hasegawa Y,
    3. Okada S,
    4. et al

    . Highly diffusion-sensitized tensor imaging of unilateral cerebral arterial occlusive disease. AJNR Am J Neuroradiol 2005;26:1498–504

    Abstract/FREE Full Text
13. 13.↵
    1. Miyamoto S,
    2. Kikuchi H,
    3. Karasawa J,
    4. et al

    . Study of the posterior circulation in Moyamoya disease. Clinical and neuroradiological evaluation. J Neurosurg 1984;61:1032–37

    PubMedWeb of Science
14. 14.↵
    1. Kim SK,
    2. Wang KC,
    3. Oh CW,
    4. et al

    . Evaluation of cerebral hemodynamics with perfusion MRI in childhood Moyamoya disease. Pediatr Neurosurg 2003;38:68–75

    CrossRefPubMed
15. 15.↵
    1. Tanaka Y,
    2. Nariai T,
    3. Nagaoka T,
    4. et al

    . Quantitative evaluation of cerebral hemodynamics in patients with Moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging—comparison with positron emission tomography. J Cereb Blood Flow Metab 2006;26:291–300

    CrossRefPubMed
16. 16.↵
    1. Yun TJ,
    2. Cheon JE,
    3. Na DG,
    4. et al

    . Childhood Moyamoya disease: quantitative evaluation of perfusion MR imaging—correlation with clinical outcome after revascularization surgery. Radiology 2009;251:216–23

    CrossRefPubMed
17. 17.↵
    1. Lee SK,
    2. Kim DI,
    3. Jeong EK,
    4. et al

    . Postoperative evaluation of Moyamoya disease with perfusion-weighted MR imaging: initial experience. AJNR Am J Neuroradiol 2003;24:741–47

    Abstract/FREE Full Text
18. 18.↵
    1. Fukui M

    . Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘Moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997;99 Suppl 2:S238–40

    PubMedWeb of Science
19. 19.↵
    1. Ostergaard L,
    2. Weisskoff RM,
    3. Chesler DA,
    4. et al

    . High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715–25

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Ostergaard L,
    2. Sorensen AG,
    3. Kwong KK,
    4. et al

    . High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 1996;36:726–36

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Houkin K,
    2. Nakayama N,
    3. Kuroda S,
    4. et al

    . Novel magnetic resonance angiography stage grading for Moyamoya disease. Cerebrovasc Dis 2005;20:347–54

    CrossRefPubMed
22. 22.↵
    1. Cao Y,
    2. Whalen S,
    3. Huang J,
    4. et al

    . Asymmetry of subinsular anisotropy by in vivo diffusion tensor imaging. Hum Brain Mapp 2003;20:82–90

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Guo AC,
    2. MacFall JR,
    3. Provenzale JM

    . Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology 2002;222:729–36

    PubMedWeb of Science
24. 24.↵
    1. Pantoni L,
    2. Garcia JH

    . Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652–59

    Abstract/FREE Full Text
25. 25.↵
    1. Helenius J,
    2. Soinne L,
    3. Salonen O,
    4. et al

    . Leukoaraiosis, ischemic stroke, and normal white matter on diffusion-weighted MRI. Stroke 2002;33:45–50

    Abstract/FREE Full Text
26. 26.↵
    1. Soinne L,
    2. Helenius J,
    3. Saimanen E,
    4. et al

    . Brain diffusion changes in carotid occlusive disease treated with endarterectomy. Neurology 2003;61:1061–65

    Abstract/FREE Full Text
27. 27.↵
    1. O'Sullivan M,
    2. Morris RG,
    3. Huckstep B,
    4. et al

    . Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004;75:441–47

    Abstract/FREE Full Text
28. 28.↵
    1. Engelter ST,
    2. Provenzale JM,
    3. Petrella JR,
    4. et al

    . The effect of aging on the apparent diffusion coefficient of normal-appearing white matter. AJR Am J Roentgenol 2000;175:425–30

    PubMedWeb of Science
29. 29.↵
    1. Mori N,
    2. Miki Y,
    3. Fushimi Y,
    4. et al

    . Cerebral infarction associated with Moyamoya disease: histogram-based quantitative analysis of diffusion tensor imaging—a preliminary study. Magn Reson Imaging 2008;26:835–40

    CrossRefPubMed
30. 30.↵
    1. Conklin J,
    2. Fierstra J,
    3. Crawley AP,
    4. et al

    . Impaired cerebrovascular reactivity with steal phenomenon is associated with increased diffusion in white matter of patients with Moyamoya disease. Stroke 2010;41:1610–16

    Abstract/FREE Full Text
31. 31.↵
    1. Jones DK

    . The effect of gradient sampling schemes on measures derived from diffusion tensor MRI: a Monte Carlo study. Magn Reson Med 2004;51:807–15

    CrossRefPubMedWeb of Science